The blood concentration and organ distribution of haloperidol at therapeutic and toxic doses in severe fatty liver disease
Authors:
- 31 May 2012
- journal article
- research article
- Published by Elsevier in Legal Medicine
- Vol. 14 (3) , 147-153
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Gene expression on liver toxicity induced by administration of haloperidol in rats with severe fatty liverLegal Medicine, 2008
- Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein−calorie malnutritionJournal of Pharmaceutical Sciences, 2004
- Effects of cysteine on the pharmacokinetics of itraconazole in rats with protein-calorie malnutritionBiopharmaceutics & Drug Disposition, 2003
- Different fatal toxicity of neuroleptics identified by autopsyEuropean Neuropsychopharmacology, 2001
- Pharmacokinetics of HaloperidolClinical Pharmacokinetics, 1999
- Acute accidental overdosage of haloperidol in childrenActa Paediatrica, 1993
- Reduced haloperidol in the post-mortem brains of haloperidol-treated patientsPsychiatry Research, 1984
- Protein Binding and Kinetics of Drugs in Liver DiseasesClinical Pharmacokinetics, 1977
- Altered Hepatic Blood Flow and Drug Disposition1Clinical Pharmacokinetics, 1976
- A physiological approach to hepatic drug clearanceClinical Pharmacology & Therapeutics, 1975